Key facts
- This page summarizes Kwan-Hong Christopher Min's Form 4/A - Amendment filing for Longeveron Inc. (LGVN).
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 12 Apr 2022, 17:38.
Kwan-Hong Christopher Min - 04 Apr 2022 Form 4/A - Amendment Insider Report for Longeveron Inc. (LGVN)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- LGVN
- Reported as of
- 04 Apr 2022
- Net transaction value
- $0
- SEC form
- 4/A - Amendment
- Accepted by SEC
- 12 Apr 2022, 17:38:20 UTC
- Original report date
- 06 Apr 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Paul Lehr, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Kwan-Hong Christopher Min filed Form 4/A - Amendment for Longeveron Inc. (LGVN) on 12 Apr 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LGVN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +2,335
- Change %
- Price
- $0.000000
- Shares after
- 2,335
- Date
- 04 Apr 2022
- Ownership
- Direct
- Footnotes
- F1, F2
LGVN
transaction
Common Stock
Tax liability
- Transaction value
- $0
- Shares
- -357
- Change %
- -15%
- Price
- $0.000000
- Shares after
- 1,978
- Date
- 04 Apr 2022
- Ownership
- Direct
- Footnotes
- F3
LGVN
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +150,000
- Change %
- +7583%
- Price
- $0.000000
- Shares after
- 151,978
- Date
- 04 Apr 2022
- Ownership
- Direct
- Footnotes
- F4, F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LGVN
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +2,335
- Change %
- Price
- $0.000000
- Shares after
- 2,335
- Date
- 04 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,335
- Exercise price
- $12.85
- Footnotes
- F6
LGVN
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +150,000
- Change %
- Price
- $0.000000
- Shares after
- 50,000
- Date
- 04 Apr 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $12.85
- Footnotes
- F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Represents the award of 2,335 Restricted Stock Units, which vested 50% on April 4, 2022, with the remaining 50% to vest on January 1, 2023.
Footnote F2
Includes 2,335 Restricted Stock Units.
Footnote F3
Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the Restricted Stock Units and does not represent a sale. This Form 4 amendment is being filed solely to report this withholding, which was not reflected in the original Form 4 filed on April 6, 2022.
Footnote F4
Represents the award of 150,000 Restricted Stock Units, which vest ratably 25% each year.
Footnote F5
Includes 151,978 Restricted Stock Units.
Footnote F6
The option vested 50% on April 4, 2022, with the remaining 50% to vest on January 1, 2023.
Footnote F7
The option vests ratably 25% each year.